A study to assess the feasibility of the daily topical application of the piperidine nitroxide, MTS-01, to reduce dermatitis combined with chemoradiotherapy in patients with anal carcinoma
Latest Information Update: 05 May 2022
At a glance
- Drugs Tempol (Primary)
- Indications Dermatitis
- Focus Therapeutic Use
Most Recent Events
- 01 Jun 2022 Results published in the International Journal of Oncology
- 05 May 2022 New trial record